328 related articles for article (PubMed ID: 7794249)
41. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
Nofer JR; Bot M; Brodde M; Taylor PJ; Salm P; Brinkmann V; van Berkel T; Assmann G; Biessen EA
Circulation; 2007 Jan; 115(4):501-8. PubMed ID: 17242282
[TBL] [Abstract][Full Text] [Related]
42. Alteration in sphingolipid metabolism: bioassays for fumonisin- and ISP-I-like activity in tissues, cells and other matrices.
Riley RT; Norred WP; Wang E; Merrill AH
Nat Toxins; 1999; 7(6):407-14. PubMed ID: 11122537
[TBL] [Abstract][Full Text] [Related]
43. Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa.
Platania CBM; Dei Cas M; Cianciolo S; Fidilio A; Lazzara F; Paroni R; Pignatello R; Strettoi E; Ghidoni R; Drago F; Bucolo C
Drug Deliv; 2019 Dec; 26(1):237-243. PubMed ID: 30883241
[TBL] [Abstract][Full Text] [Related]
44. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
[TBL] [Abstract][Full Text] [Related]
45. De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells.
Berdyshev EV; Gorshkova IA; Usatyuk P; Zhao Y; Saatian B; Hubbard W; Natarajan V
Cell Signal; 2006 Oct; 18(10):1779-92. PubMed ID: 16529909
[TBL] [Abstract][Full Text] [Related]
46. Serine palmitoyltransferase, the first step enzyme in sphingolipid biosynthesis, is involved in nonhost resistance.
Takahashi Y; Berberich T; Kanzaki H; Matsumura H; Saitoh H; Kusano T; Terauchi R
Mol Plant Microbe Interact; 2009 Jan; 22(1):31-8. PubMed ID: 19061400
[TBL] [Abstract][Full Text] [Related]
47. Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids.
Schmelz EM; Roberts PC; Kustin EM; Lemonnier LA; Sullards MC; Dillehay DL; Merrill AH
Cancer Res; 2001 Sep; 61(18):6723-9. PubMed ID: 11559543
[TBL] [Abstract][Full Text] [Related]
48. Reactions of serine palmitoyltransferase with serine and molecular mechanisms of the actions of serine derivatives as inhibitors.
Ikushiro H; Hayashi H; Kagamiyama H
Biochemistry; 2004 Feb; 43(4):1082-92. PubMed ID: 14744154
[TBL] [Abstract][Full Text] [Related]
49. Myriocin treatment affects lipid metabolism in skeletal muscles of rats with streptozotocin-induced type 1 diabetes.
Kurek K; Garbowska M; Ziembicka DM; Łukaszuk B; Rogowski J; Chabowski A; Górski J; Żendzian-Piotrowska M
Adv Med Sci; 2017 Mar; 62(1):65-73. PubMed ID: 28189121
[TBL] [Abstract][Full Text] [Related]
50. Sphingolipid biosynthesis in cultured neurons. Down-regulation of serine palmitoyltransferase by sphingoid bases.
Mandon EC; van Echten G; Birk R; Schmidt RR; Sandhoff K
Eur J Biochem; 1991 Jun; 198(3):667-74. PubMed ID: 1646717
[TBL] [Abstract][Full Text] [Related]
51. Characterization of a novel, potent, and specific inhibitor of serine palmitoyltransferase.
Zweerink MM; Edison AM; Wells GB; Pinto W; Lester RL
J Biol Chem; 1992 Dec; 267(35):25032-8. PubMed ID: 1460005
[TBL] [Abstract][Full Text] [Related]
52. Sphingolipids are essential for the growth of Chinese hamster ovary cells. Restoration of the growth of a mutant defective in sphingoid base biosynthesis by exogenous sphingolipids.
Hanada K; Nishijima M; Kiso M; Hasegawa A; Fujita S; Ogawa T; Akamatsu Y
J Biol Chem; 1992 Nov; 267(33):23527-33. PubMed ID: 1429697
[TBL] [Abstract][Full Text] [Related]
53. Total synthesis of a novel immunosuppressant, myriocin (thermozymocidin, ISP-I), and Z-myriocin.
Yoshikawa M; Yokokawa Y; Okuno Y; Murakami N
Chem Pharm Bull (Tokyo); 1994 Apr; 42(4):994-6. PubMed ID: 8020136
[TBL] [Abstract][Full Text] [Related]
54. The effects of serine palmitoyltransferase inhibitor, ISP-I, on UV-induced barrier disruption in the stratum corneum.
Mizukoshi K; Oshima H; Matsumoto K; Hirose R; Fujita T
Biol Pharm Bull; 2010; 33(12):2008-12. PubMed ID: 21139242
[TBL] [Abstract][Full Text] [Related]
55. Myriocin-mediated up-regulation of hepatocyte apoA-I synthesis is associated with ERK inhibition.
Glaros EN; Kim WS; Garner B
Clin Sci (Lond); 2010 Mar; 118(12):727-36. PubMed ID: 20102334
[TBL] [Abstract][Full Text] [Related]
56. Expression of the ORMDLS, modulators of serine palmitoyltransferase, is regulated by sphingolipids in mammalian cells.
Gupta SD; Gable K; Alexaki A; Chandris P; Proia RL; Dunn TM; Harmon JM
J Biol Chem; 2015 Jan; 290(1):90-8. PubMed ID: 25395622
[TBL] [Abstract][Full Text] [Related]
57. The chemical basis of serine palmitoyltransferase inhibition by myriocin.
Wadsworth JM; Clarke DJ; McMahon SA; Lowther JP; Beattie AE; Langridge-Smith PR; Broughton HB; Dunn TM; Naismith JH; Campopiano DJ
J Am Chem Soc; 2013 Sep; 135(38):14276-85. PubMed ID: 23957439
[TBL] [Abstract][Full Text] [Related]
58. D-Serine inhibits serine palmitoyltransferase, the enzyme catalyzing the initial step of sphingolipid biosynthesis.
Hanada K; Hara T; Nishijima M
FEBS Lett; 2000 May; 474(1):63-5. PubMed ID: 10828452
[TBL] [Abstract][Full Text] [Related]
59. [Effect of myriocin on the expression of cyclinD1 in high glucose-induced hypertrophy mesangial cells].
Xiao ZH; Zhou JH; Wu HS
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Aug; 13(8):677-9. PubMed ID: 21849123
[TBL] [Abstract][Full Text] [Related]
60. [Current topics for the sphingolipid-mediated signaling pathway].
Sun Y; Tanoue D; Kozutsumi Y
Tanpakushitsu Kakusan Koso; 2001 May; 46(6):706-12. PubMed ID: 11360494
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
